Bepridil versus nifedipine for ventricular tachycardia induced in the late postinfarction phase in conscious dogs.
The effects of the two calcium antagonists bepridil and nifedipine on induced ventricular tachyarrhythmias were studied by programmed electrical stimulation in 15 dogs, 4-8 days after myocardial infarction. Recordings from the infarcted and normal anterior wall of the left ventricle were obtained with an epicardial implanted 'composite' electrode. Bepridil (5 mg/kg) or nifedipine (0.025 mg/kg) were administered i.v. on different days and testing was repeated. Sustained ventricular tachycardia was prevented or significantly slowed by bepridil in 11/12 experiments compared with none of 9 experiments with nifedipine. Paradoxically, in 10/15 dogs nifedipine accelerated arrhythmias or even provoked ventricular fibrillation. Bepridil prolonged refractoriness of infarcted myocardium by 15 +/- 4% (mean +/- SD, p less than 0.01), which was greater than the increase it produced in the effective refractory period of normal tissue (9.0 +/- 3.8%) or QTc interval (11 +/- 5.5%). In contrast, nifedipine significantly shortened these parameters. Both drugs did not influence conduction in infarcted and normal zones as indicated by unchanged late potentials, QRS duration and normal-zone electrograms, respectively. The data indicate that the antiarrhythmic action of bepridil was predominantly related to the prolongation of ventricular refractoriness and repolarization (class III effects).
Brachmann
J
J
Department of Cardiology, University of Heidelberg, FRG.
Aidonidis
I
I
Dembowsky
K
K
Seller
H
H
Kuebler
W
W
D000818:Animals; D015764:Bepridil; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002304:Cardiac Pacing, Artificial; D003243:Consciousness; D004285:Dogs; D004562:Electrocardiography; D009203:Myocardial Infarction / Q000150:complications*; D009543:Nifedipine / Q000627:therapeutic use*; D011759:Pyrrolidines / Q000627:therapeutic use*; D013610:Tachycardia / Q000188:drug therapy* / Q000209:etiology
D002121:Calcium Channel Blockers; D011759:Pyrrolidines; D015764:Bepridil; D009543:Nifedipine